Corporate Service Portfolio

Our Chemistry, Manufacturing and Controls (CMC) specialists help customers manage the product's compliance at every step, from clinical development to market authorization. With decades of experience, our experts provide support in navigating regulatory milestones, including site registration, product regi...

Our Vetter Development Services help biopharma customers lay a foundation of scalability, quality, and sustainable value for drug product profiles. We support drug developers in navigating key steps, decisions, and transitions in the product development cycle. This includes primary packaging evaluation, pr...

For over 40 years, our fill and finish services have helped to keep the world supplied with injectable therapies, many of which are lifesaving. Our partnerships with customers start in the first steps of clinical manufacturing through commercial-scale filling and beyond, including management throughout the...

The injectable drug market is rapidly evolving and includes an array of delivery devices from autoinjectors to pens and other intuitive formats. We provide partnership for drug owners driven by the top-quality, complex considerations and flexibility expected. These services include assembly process des...

From a drug product’s first raw materials to its release-ready batches, our experts rigorously evaluate and verify a product’s quality at key steps throughout the manufacturing process. Analytical services include material testing to verify product quality from the early stages of development, cGMP-com...

V-OVS® next is a new evolution of the V-OVS® Luer Lock closure system: A product that has helped shape the market for 20+ years. Several innovative updates further enhance the system’s functionality, including an optimized opening mechanism and a streamlined design that fits an even wider range of syri...

The latest in our series for the CPHI Podcast Series focuses on partnerships, specifically those between pharma companies and CDMOs. Expert Christine Fürst from Vetter comments on how to make successful and lasting partnerships in the industry. 

For over four decades, pharma and biotech companies around the world have relied on us to put their parenteral medications on a path to success. We’re proud to help our customers advance their valuable products with innovative services, cutting-edge technology, and flexible, robust, scalable processes that set our partnership apart.

Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 

This presentation looks at the crucial role of syringe closure systems in the field of prefilled syringes and injection devices, offering scientific insights into container closure development. With extensive experience of legacy closure systems, our company explores the potential of integrating historical knowledge with contemporary development methods to create a novel closure system. This presentation will showcase how efficient development strategies and state-of-the-art methods can be used to create a development program that is based on history, is driven by innovation and adheres to the latest combination product regulations.

Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.